Correction to: Perez et al., "A short cis-acting motif in the M112-113 promoter region is essential for IE3 to activate M112-113 gene expression and is important for murine cytomegalovirus replication" [Journal of Virology, 87, 5, (2013) (2639-2647)] doi: 10.1128/JVI.03171-12;A short cis-acting motif in the M112-113 promoter region is essential for IE3 to activate M112-113 gene expression and is important for murine cytomegalovirus replication

Journal of Virology

Volumn 87, Issue 5, 2013, Pages 2639-2647

  Perez, Kareni J ^a   Martínez, Francisco Puerta ^a   Cosme Cruz, Ruth ^a   Perez Crespo, Neysa M ^a   Tang, Qiyi ^a  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

TATA BINDING PROTEIN; TFIID TRANSCRIPTION FACTOR COMPLEX; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL STRAIN 3T3; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA SEQUENCE; GENE ACTIVATION; GENE EXPRESSION; IMMEDIATE EARLY 3 ACTIVATING MOTIF; IMMEDIATE EARLY 3 GENE; IMMEDIATE EARLY GENE; M112 113 GENE; MURINE CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; TATA BOX; VIRUS GENE; VIRUS MUTANT; VIRUS REPLICATION;

EID: 84874754474     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01527-17     Document Type: Erratum

References (46)

1. Mocarski ES, Jr, Shenk T, Pass RF. 2006. Cytomegaloviruses, 5th ed. Lippincott Williams &Wilkins, Philadelphia, PA.
2. Reddehase MJ, Simon CO, Seckert CK, Lemmermann N, Grzimek NK. 2008. Murine model of cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 325:315-331.
3. Angulo A, Ghazal P, Messerle M. 2000. The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth. J. Virol. 74: 11129-11136.
4. Keil GM, Ebeling-Keil A, Koszinowski UH. 1987. Immediate-early genes of murine cytomegalovirus: location, transcripts, and translation products. J. Virol. 61:526-533.
5. Messerle M, Buhler B, Keil GM, Koszinowski UH. 1992. Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. J. Virol. 66:27-36.
6. Martinez FP, Cosme RS, Tang Q. 2010. Murine cytomegalovirus major immediate-early protein 3 interacts with cellular and viral proteins in viral DNAreplication compartments and is important for early gene activation. J. Gen. Virol. 91:2664-2676.
7. Tang Q, Li L, Maul GG. 2005. Mouse cytomegalovirus early M112/113 proteins control the repressive effect of IE3 on the major immediate-early promoter. J. Virol. 79:257-263.
8. Buhler B, Keil GM, Weiland F, Koszinowski UH. 1990. Characterization of the murine cytomegalovirus early transcription unit e1 that is induced by immediate-early proteins. J. Virol. 64:1907-1919.
9. White EA, Spector DH. 2007. Early viral gene expression and function. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (ed). Cambridge University Press, Cambridge, United Kingdom.
10. Ciocco-Schmitt GM, Karabekian Z, Godfrey EW, Stenberg RM, Campbell AE, Kerry JA. 2002. Identification and characterization of novel murine cytomegalovirus M112-113 (e1) gene products. Virology 294: 199-208.
11. Pari GS, Anders DG. 1993. Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus ori-Lyt-dependent DNA replication. J. Virol. 67:6979-6988.
12. Sarisky RT, Hayward GS. 1996. Evidence that the UL84 gene product of human cytomegalovirus is essential for promoting oriLyt-dependent DNA replication and formation of replication compartments in cotransfection assays. J. Virol. 70:7398-7413.
13. Kagele D, Rossetto CC, Tarrant MT, Pari GS. 2012. Analysis of the interactions of viral and cellular factors with human cytomegalovirus lytic origin of replication, oriLyt. Virology 424:106-114.
14. Ahn JH, Jang WJ, Hayward GS. 1999. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia proteinassociated nuclear bodies (PODs or ND10). J. Virol. 73:10458-10471.
15. Park MY, Kim YE, Seo MR, Lee JR, Lee CH, Ahn JH. 2006. Interactions among four proteins encoded by the human cytomegalovirus UL112-113 region regulate their intranuclear targeting and the recruitment of UL44 to prereplication foci. J. Virol. 80:2718-2727.
16. Arai Y, Ishiwata M, Baba S, Kawasaki H, Kosugi I, Li RY, Tsuchida T, Miura K, Tsutsui Y. 2003. Neuron-specific activation of murine cytomegalovirus early gene e1 promoter in transgenic mice. Am. J. Pathol. 163:643-652.
17. Wells R, Stensland L, Vieira J. 2009. The human cytomegalovirus UL112-113 locus can activate the full Kaposi's sarcoma-associated herpesvirus lytic replication cycle. J. Virol. 83:4695-4699.
18. Schumacher U, Handke W, Jurak I, Brune W. Mutations in the M112/ M113 coding region facilitate murine cytomegalovirus replication in human cells. J. Virol. 84:7994-8006.
19. Schwartz R, Helmich B, Spector DH. 1996. CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter. J. Virol. 70:6955-6966.
20. Lang D, Gebert S, Arlt H, Stamminger T. 1995. Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB. J. Virol. 69:6030-6037.
21. Rodems SM, Clark CL, Spector DH. 1998. Separate DNA elements containing ATF/CREB and IE86 binding sites differentially regulate the human cytomegalovirus UL112-113 promoter at early and late times in the infection. J. Virol. 72:2697-2707.
22. Arlt H, Lang D, Gebert S, Stamminger T. 1994. Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter. J. Virol. 68:4117-4125.
23. Spector DH. 1996. Activation and regulation of human cytomegalovirus early genes. Intervirology 39:361-377.
24. Hengel H, Lucin P, Jonjic S, Ruppert T, Koszinowski UH. 1994. Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J. Virol. 68:289-297.
25. Loh LC, Keeler VD, Shanley JD. 1999. Sequence requirements for the nuclear localization of the murine cytomegalovirus M44 gene product pp50. Virology 259:43-59.
26. Wu CA, Carlson ME, Henry SC, Shanley JD. 1999. The murine cytomegalovirus M25 open reading frame encodes a component of the tegument. Virology 262:265-276.
27. Ellison TJ, Izumiya Y, Izumiya C, Luciw PA, Kung HJ. 2009. A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus. Virology 387:76-88.
28. Atanasiu C, Lezina L, Lieberman PM. 2005. DNA affinity purification of Epstein-Barr virus OriP-binding proteins. Methods Mol. Biol. 292:267-276.
29. Dignam JD, Lebovitz RM, Roeder RG. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
30. Wagner M, Jonjic S, Koszinowski UH, Messerle M. 1999. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73:7056-7060.
31. Warden C, Tang Q, Zhu H. 2011. Herpesvirus BACs: past, present, and future. J. Biomed. Biotechnol. 2011:124595.
32. Fortunato EA, McElroy AK, Sanchez I, Spector DH. 2000. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol. 8:111-119.
33. Loregian A, Coen DM. 2006. Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase. Chem. Biol. 13:191-200.
34. Stinski MF, Isomura H. 2008. Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency. Med. Microbiol. Immunol. 197:223-231.
35. Stinski MF, Petrik DT. 2008. Functional roles of the human cytomegalovirus essential IE86 protein. Curr. Top. Microbiol. Immunol. 325:133-152.
36. Salvant BS, Fortunato EA, Spector DH. 1998. Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J. Virol. 72:3729-3741.
37. Wiebusch L, Hagemeier C. 1999. Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G(1). J. Virol. 73:9274-9283.
38. Wiebusch L, Neuwirth A, Grabenhenrich L, Voigt S, Hagemeier C. 2008. Cell cycle-independent expression of immediate-early gene 3 results in G1 and G2 arrest in murine cytomegalovirus-infected cells. J. Virol. 82:10188-10198.
39. Tang Q, Maul GG. 2003. Mouse cytomegalovirus immediate-early protein 1 binds with host cell repressors to relieve suppressive effects on viral transcription and replication during lytic infection. J. Virol. 77:1357-1367.
40. Taylor RT, Bresnahan WA. 2005. Human cytomegalovirus immediateearly 2 gene expression blocks virus-induced beta interferon production. J. Virol. 79:3873-3877.
41. Stenberg RM. 1996. The human cytomegalovirus major immediate-early gene. Intervirology 39:343-349.
42. Ghazal P, Visser AE, Gustems M, Garcia R, Borst EM, Sullivan K, Messerle M, Angulo A. 2005. Elimination of ie1 significantly attenuates murine cytomegalovirus virulence but does not alter replicative capacity in cell culture. J. Virol. 79:7182-7194.
43. Mendelson M, Monard S, Sissons P, Sinclair J. 1996. Detection of endogenous human cytomegalovirus in CD34 bone marrow progenitors. J. Gen. Virol. 77(Pt 12):3099-3102.
44. Vannini A, Cramer P. 2012. Conservation between the RNA polymerase I, II, and III transcription initiation machineries. Mol. Cell 45:439-446.
45. Papai G, Weil PA, Schultz P. 2011. New insights into the function of transcription factor TFIID from recent structural studies. Curr. Opin. Genet. Dev. 21:219-224.
46. Lee TI, Young RA. 2000. Transcription of eukaryotic protein-coding genes. Annu. Rev. Genet. 34:77-137.